Morgan Stanley Private Equity Asia
Hong Kong SARmorganstanley.com
Overview
Morgan Stanley Private Equity Asia specializes in privately negotiated minority investments in companies with substantial business operations in the Asia-Pacific region . They target fast-growing businesses with strong brands, sustainable competitive advantages, and proven track records of financial performance . On a selective basis, they also pursue control investments where they believe they can add significant value to the business . Established in 1993, they invest primarily in highly structured minority investments and control buyouts in growth-oriented companies .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Kogta Financial India | Jun 2024 | Series E | Co-investor |
| Maiva Pharma | May 2024 | Private Equity | Lead |
| Kogta Financial India | Mar 2022 | Series D | Co-investor |
| Fullife Healthcare | Dec 2021 | Series C | Lead |
| Ummeed Housing Finance | Sep 2021 | Series E | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.